2020
DOI: 10.37766/inplasy2020.5.0102
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy and safety of Chinese herbal medicine in the treatment of Alzheimer's disease: a systematic review and IPD meta-analysis

Abstract: Review question / Objective: This review is intended to explore the efficacy and safety of Chinese Herbal Medicine in the treatment of Alzheimer's disease in comparison with conventional treatment, such as donepezil. Condition being studied: Alzheimer's d i s e a s e ( A D ) i s a p r o g r e s s i v e neurodegenerative disease characterized by the accumulation of amyloid beta in the INPLASY 1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Meta-analyses of other treatments, such as like glucagon-like peptide-1 receptor agonists and negative allosteric modulators of 5-hydroxytryptamine 2A receptors, were also conducted by the researchers across the globe. 75,76 Our meta-analysis showed that all 3 acetylcholinesterase inhibitors now in use, i.e., donepezil, galantamine and galantamine, significantly enhance patients' cognitive abilities. However, given to the substantial heterogeneity among the included trials, caution should be exercised in interpreting the results of galantamine and rivastigmine.…”
Section: Discussionmentioning
confidence: 93%
“…Meta-analyses of other treatments, such as like glucagon-like peptide-1 receptor agonists and negative allosteric modulators of 5-hydroxytryptamine 2A receptors, were also conducted by the researchers across the globe. 75,76 Our meta-analysis showed that all 3 acetylcholinesterase inhibitors now in use, i.e., donepezil, galantamine and galantamine, significantly enhance patients' cognitive abilities. However, given to the substantial heterogeneity among the included trials, caution should be exercised in interpreting the results of galantamine and rivastigmine.…”
Section: Discussionmentioning
confidence: 93%